Sunday, November 29 | 1:10 p.m.- 1:20 p.m. | S4-SSCH02-2 | Room E451A
Lung-RADS findings could contribute risk information for patients who do not meet conventional low-dose CT (LDCT) screening eligibility criteria, according to this presentation.
Beijing-based researchers are proposing that Lung-RADS findings could offer complementary risk information for patients who do not meet conventional low-dose CT (LDCT) screening eligibility criteria.
Most LDCT-detected lung cancers appear in individuals who don't meet U.S. Preventive Services Task Force (USPSTF)-based screening eligibility criteria, presenter Yanyan Tang, PhD, of the National Clinical Research Center for Cancer in Beijing, and colleagues noted, and more than half of these USPSTF-ineligible lung cancers are categorized as Lung-RADS 3 or higher findings.
The group analyzed an LDCT screening cohort of 30,468 patients, classifying those with pathologically confirmed lung cancer as either USPSTF-eligible or USPSTF-ineligible. The study's primary outcome was the proportion of USPSTF-ineligible lung cancers categorized as Lung-RADS 3 (probably benign) or higher and Lung-RADS 4B or 4X (very suspicious).
Of the total number of patients, 289 were diagnosed with lung cancer. Tang and colleagues also reported the following:
· 45 of 289 cancers (15.6%) met USPSTF-based LDCT screening eligibility criteria.
· 244 of 289 cancers (84.4%), were USPSTF-ineligible.
· 55.7% of USPSTF-ineligible lung cancers were categorized as Lung-RADS 3 or higher.
· 49.2% USPSTF-ineligible lung cancers were Lung-RADS 4B or 4X.
· 62.7% of USPSTF-ineligible lung cancers were found in women, and 88.5% in never-smokers.
Using Lung-RADS findings in this way could help identify clinically relevant lung cancers missed by age- and smoking-based eligibility criteria, particularly among women and never-smokers, Tang's group concluded.
What else did they find?



